HEMA Biologics is a privately held biopharmaceutical company based in Louisville, KY, dedicated to supporting individuals living with rare bleeding disorders, particularly hemophilia A or B with inhibitors. They are highly focused on providing personalized disease management services and resources, and are committed to developing high-quality investigational therapies to improve the daily lives of patients.
With a strong emphasis on collaboration and empathy, HEMA Biologics works closely with patients, healthcare professionals, and the broader community to meet the unique needs of those living with rare bleeding disorders. As a responsible company rooted in Europe, they are proud to partner with LFB SA, a French state-owned company, to distribute and commercialize their products in the United States.
Generated from the website